Monthly Archives: September 2020

Potentiates vascularization of neurotrophic factors during nerve repair process is beneficial for nerve regeneration

In the present study, both the protein levels of BDNF and NGF were significantly higher in the L-CCH+OW group than those in the L-CCH group at 2 weeks after surgery, which might be, at least in part, responsible for the improved nerve regeneration in the L-CCH+OW group. Despite the finding that elevated protein levels of BDNF and NGF was observed in the L-CCH+OW group, the source of BDNF and NGF was not identified in the present study. SCs regain the ability of synthesizing neurotrophic factors after peripheral nerve injury, thus are probably the main source of BDNF and NGF. In addition, omentum might be served as a pool for BDNF. It has been shown that BDNF expression was noted in vascular endothelial cells, which were abundantly found in omentum. The omentum implanted at the local site of nerve scaffold might contribute to the up-regulation of BDNF observed in the LCCH+OW group. The mechanism underlying the up-regulated expression of BDNF and NGF needs to be clarified in the future studies. Large peripheral nerve defects are frequently caused by trauma, and patients with those injuries should be advised to seek emergency surgery immediately. Otherwise, the dispersed axonal growth would lead to neuroma formation, and the atrophy of denervated target organs would increase the risk of permanent disability. Autologous omentum is not only free of ethical issues but also easily harvested through laparoscopic techniques without many intraabdominal complications associated with laparotomy. In addition, omentum is easy to integrate with local sites and avoid questions regarding immunogenicity, thus exhibits therapeutic potential in the immediate repair of large nerve defects while combined with nerve scaffolds. The encouraging outcomes in the present study indicate that the combined usage of omentum and nerve scaffolds, if further confirmed in larger animals and even humans, may serve as a potent alternative to nerve autografts. Moreover, nerve autograft contains Schwann cells and basal lamina micro-channels, which are responsible for axonal regeneration achieved by nerve autograft, while the longitudinally oriented micro-channels within the L-CCH scaffold and omentum wrapped around the channels might largely account for axonal regeneration achieved by the omentum-wrapped LCCH scaffold. Although the nerve regeneration achieved by omentum-wrapped L-CCH scaffold is not superior to that by nerve autograft, it is still encouraging that these two grafts achieved similar performance in promoting nerve regeneration in the present study. It can be hypothesized that seeding SCs and incorporating neurotrophic factors into the omentum-wrapped LCCH scaffold may achieve better nerve regeneration and functional recovery than nerve autograft, which will be investigated in our future studies. In conclusion, the combined usage of omentum and the L-CCH scaffold described here has several potential advantages over other strategies for promoting large nerve defect regeneration. Firstly, the L-CCH scaffold is relatively easy to prepare, handle, store, and sterilize. Secondly, the longitudinally oriented micro-channels in the L-CCH scaffold are capable of guiding the linear growth of Reversine regenerated axons, and the interconnected porous structure may facilitate penetration of blood vessels.

TTP has been elucidated via crystallography clear how binding affinity and specificity are achieved in other cases

Because functional AREs normally contain clustered repeats of the characteristic AUUUA motif, cooperative binding of several factors in close proximity has been proposed. Small non-coding RNAs such as microRNAs and short MG132 interfering RNAs also lead to the destabilization and translational repression of cognate mRNAs. They are bound by proteins of the Argonaute family and confer target mRNA specificity to the RNA-induced silencing complex. Based on data obtained in Drosophila and human cell cultures, Jing et al. proposed that miRNAs with appropriate sequence complementarity can recruit RISC to the ARE and thus mediate part of the repressive effect. In another report, Vasudevan and Steitz demonstrated that recognition of an ARE by miRNAloaded RISC, in association with the Fragile-X mental retardation-related protein 1, activates mRNA translation in quiescent cells. This is surprising given that AREs and miRNAs are both generally regarded as negative regulators. Cross-talk between the miRNA and the ARE pathway has also been observed in liver cells. When grown under normal conditions, CAT-1 mRNA is targeted by miR-122, leading to its re-localization into P-bodies and translational suppression. Upon amino acid starvation, the ARE-binding HuR protein is translocated into the cytoplasm and recruited to an ARE in the CAT-1 mRNA, downstream of the miR-122 binding site. Recruitment of HuR causes miR-122 to dissociate, whereby CAT-1 mRNA is released from P-bodies and resumes translation. While most work on ARE-mediated regulation has been performed in mammalian systems, it has become clear that Drosophila melanogaster is not only capable of recognizing and degrading mRNAs containing mammalian AREs, but also uses this system to control endogenous transcripts, e.g. the mRNA coding for the antimicrobial peptide cecropin A1. Moreover, the TTP-homolog tis-11 was found to be essential for this regulation in Drosophila and overexpression of tis-11 results in a further increase of the mRNA degradation rate. We revisited the proposal by Jing et al. that miRNAs are required for degradation of ARE-containing mRNAs. To this end, we examined AU-rich element mediated decay in mouse embryonic fibroblasts lacking the essential miRNA biogenesis factor dicer, and found that the half-life of endogenously expressed ier3 mRNA, an ARE-containing transcript, is unchanged. In cultured Drosophila S2 cells we observed that ARE-containing reporter mRNAs as well as endogenous cecA1 mRNA are repressed in a tis-11 dependent manner. Again, this repression did not depend on components of the miRNA or siRNA pathways. Direct inhibition or overexpression of miRNAs with potential sequence-complementarity to the ARE did not change reporter gene expression. Finally, we demonstrate that the putative precursor of Drosophila miR-289 – the miRNA that was originally found responsible for ARE recognition in Drosophila – does not give rise to a mature miRNA. We therefore conclude that in mouse embryonic fibroblasts and Drosophila S2 cells, ARE-mediated post-transcriptional control is independent of the mi/siRNA pathways. ECF-type ABC transporters are widespread among prokaryotes and involved in uptake of vitamins, transition metal cations, intermediates of salvage pathways and probably other compounds.

Performed in hantaviruses can interfere with several signalling pathways that are involved in innate immune activation and function

For CPXV, viral titers in supernatants increased dramatically 48 hpi at the same time point as clear cytopathic effects were observed, indicating an inefficient control of the infection in these cells. Although displaying a lytic infection, production of viral LV progeny did not increase with increased amounts of lyzed cells, indicating a less efficient replication than for CPXV. Natural infections of bank voles with CPXV and LV are believed to occur without symptoms. If these infections also cause lytic infections of cells in the natural host in vivo remains to be shown. Interestingly, PUUV replicated efficiently, showing increased production of progeny virus over time, without clearly inducing IFN-b or Mx2. This suggests a strong PUUV-mediated repression of viral recognition and/or inhibition of IFN-activation in these cells. In contrast infection of human fibroblasts with the same PUUV-stock resulted in induction of IFN-b and MxA, and inhibition of progeny virus production over time, suggesting that PUUV regulate bank vole cells in a different manner than human cells. In contrast to what was AMN107 observed for PUUV, both IFN-b and Mx2 were clearly induced in TBEV-infected VEFs, and virus production did not increase over time. Hence, these results indicate an innate immune reaction that keeps TBEV in check, although not strong enough to completely inhibit progeny virus production. This in vitro model together with our initial characterizations will simplify future studies addressing virus-host interactions between bank vole borne viruses and natural host-derived cells, including possible regulatory effects on innate immune activation as well as on antiviral responses. The model presented here could easily be extended to other natural host species for hantaviruses, and hence facilitate future investigations aiming at understanding how hantavirus regulation of natural host cells differs from that of human cells, and might also provide a reliable method for isolation of wild-type viruses. The genetic diversity within bank voles might lead to differences in outcome of infection. We believe that isolations of VEFs from genetically different bank voles isolated in different geographical localities, can serve as a useful tool for studies addressing the effect of genetic differences on innate immune responses and other markers of infection, which might lead to a better understanding of bank vole-borne virus pathogenesis. Further, information on the role of infected fibroblasts during viral infections is not available and hopefully the VEF system presented here provide new knowledge about infections of bank vole cells in general. Experimental infection of natural hosts with hantaviruses have earlier been established for Sin Nombre virus, Seoul virus and PUUV. In addition, genes encoding deer mouse chemokines and cytokines have been sequenced, thereby enabling studies of immune responses during SNV-infection of the natural host in vivo. However, to our knowledge this is the first report of an in vitro-model based on cells from a natural hantavirus host. It is not known why hantavirus infection in humans causes disease, while the infections in natural hosts are asymptomatic.

Maternal taurine deficiency is also associated with arrest in fetal growth affecting beta cell development and insulin sensitivity

The resulting changes in placental development are reflected by significant reduction in fetal weights. These data suggest that alcohol exposure as well as acetaldehyde can adversely affect placental growth throughout pregnancy. SGHPL-4 cells were derived from transformed first trimester extravillous cytotrophoblasts and have retained invasive characteristics. A strong trend towards inhibition of migration was observed through a PF-04217903 956905-27-4 matrigel barrier after ethanol and acetaldehyde exposure; limitations of access to cells for this study precluded more experiments to confirm a statistically significant effect. However, other studies using immortalised extravillous cytotrophoblast cells have shown that motility can be inhibited at approximately 17 mM of alcohol over 48 hours. In rat, ethanol exposure reduces the number of invasive trophoblast giant cells and induces cell death in the spongiotrophoblast layer. Proficient extravillous cytotrophoblast invasion in the early first trimester plays a critical role in transforming maternal arteries, supporting a stable low pressure supply of nutrients and gases. Defective invasion of extravillous cytotrophoblasts with reduced arterial remodelling is associated with a range of pregnancy pathologies including FGR. Further work will be needed to assess the impact of alcohol consumption on invasion and vascular remodelling in the first trimester placental bed. The placental system b amino acid transporter is responsible for providing the fetus with taurine, a sulphur-amino acid with antioxidant properties that may be neuroprotective during fetal development. This study demonstrates detrimental effects of clinically relevant ethanol concentrations on the taurine transporter in both BeWo, an epithelioid trophoblast cell line of lower invasive potential, and explants of first trimester placenta. Even at the lowest concentration used, equivalent to an approximate a blood alcohol concentration of 0.05, is able to disrupt normal taurine transporter function. In humans, taurine is maternally derived during pregnancy as fetal production is insufficient to support development. Maternal taurine deprivation in animal models demonstrates decreased fertility and increased incidence of fetal resorption and stillbirth in feline and rodent models. Surviving neonates have lower birth weight, decreased brain weight and experience slower growth. In the complete absence of taurine transporters, knockout mice are significantly growth restricted at birth, and have visual, auditory, and muscular alterations in adulthood compared to their wild types. Reduced placental taurine concentrations have been correlated with FGR, where system b activity is significantly restricted in placentas of FGR fetuses compared to normal pregnancies. This reduction in placental system b activity is observable even in pregnancies with higher risk of FGR. At 40 mM alcohol, the inhibition of taurine transporter function is potentially exposing the fetus to periods of significant deprivation.

To ensure evidence-based clinical practice further rigorous placebo-controlled randomized trials are warranted

Provide information about standardization including compositions, quality control, detailed regimen, and duration of treatment. In summary, the reported beneficial effect from Chinese herbs for H1N1 influenza can not be taken as confirmative conclusion. The following methodological issues should be addressed: methods used to generate allocation sequence and allocation GW786034 concealment; double blinding with the use of adequate placebo; clear descriptions of withdrawal/dropout during the trial and use of intention-to-treat analysis; and reporting trials according to the CONSORT Statement . In the literature searching, we identified several registered trials of Chinese herbs for H1N1 influenza. We hope with the publication of these ongoing trials in the future, new high-qualified evidence will arise to provide clinical evidence for the use of Chinese herbs for the H1N1 influenza. Lysosomal storage diseases are a form of metabolic disorder caused by inherited deficiencies of specific lysosomal enzymes, which lead to the accumulation of nonmetabolized macromolecules. The frequency of LSDs as a group varies among populations from 7 to 25 per 100.000. Niemann Pick disease type C1 is a LSD of autosomal recessive inheritance, caused by mutations in the NPC1 gene that encodes for a large transmembrane protein. In Western Europe, the birth incidence of NPC1 has been estimated to be 1 in 150.000. Cells harbouring mutations in NPC1 gene accumulate lowdensity lipoprotein -derived cholesterol in late endosomes/ lysosomes and exhibit defects in lipid trafficking and storage. Affected patients develop ataxia, motor dysfunction and organomegaly. The neuropathological features are characterized by progressive loss of Purkinje cells in the cerebellum, and neurons in the basal ganglia and brain stem. Also, cytoskeletal changes have been demonstrated in neurons in form of neurofibrillary tangles, consisting of hyperphosphorylated tau protein. The initial clinical manifestations of NPC1 disease vary strongly, being neurological, pulmonary or hepatic in nature. The lifespan of patients varies between a few days until over 60 years of age – the majority of cases, however, die between 10 and 25 years of age. One possibility to alleviate the severity of disease could be blocking the intestinal absorption of cholesterol with Ezetimibe or inhibition of protein hyperphosphorylation. Blocking of cyclin-dependent kinases reveal a strong inhibitory effect on protein phosphorylation, being favourable for neural cell survival and thus improving locomotor defects in NPC1 knock-out mice. However, the inhibition of extracellular signal regulated kinases did not alter neurological indices of NPC1 disease in this mouse model. A very promising approach for the treatment of NPC1 is the substrate reduction therapy with the blood-brain barrier crossing small molecule miglustat, which has been reported to reduce lipid accumulation in NPC12/2 mice, thus leading to delay in onset of clinical signs and increasing lifespan.